The entirety of Lixis’ stock is acquired, a leading competitor in the Latin American market with headquarters in Argentina, boasting over 17 years of experience in developing vision systems and pharmaceutical serialization.
The entirety of Lixis’ stock is acquired, a leading competitor in the Latin American market with headquarters in Argentina, boasting over 17 years of experience in developing vision systems and pharmaceutical serialization.
